10x Genomics (NASDAQ:TXG) Given New $18.00 Price Target at Stifel Nicolaus
Genomics (NASDAQ:TXG – Get Free Report) had its price objective reduced by equities researchers at Stifel Nicolaus from ...
10x, Harvard settle genomics patent dispute with Vizgen during trial
Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...
Hosted on MSN2d
10x Genomics (NASDAQ:TXG) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations
Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results , but sales fell by 10.3% year on year to $165 million.
10x Genomics price target lowered to $15 from $18 at TD Cowen
TD Cowen analyst Dan Brennan lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps a Hold rating on the shares. The ...
Impacts1d
Top Crypto Investment for February 2025: This Altcoin with Real-World Utility Is Poised for 10x Returns
As investors seek high-growth opportunities in the evolving crypto market, projects with strong fundamentals and real-world ...
blockonomi1d
The XRP Holders That Are Earning Extra With 1Fuel (OFT) Have Kept The Launch Very Quiet Until Now. Will This 10X Opportunity Pay Off?
While the spotlight has been on the SEC’s legal battles and XRP’s market movements, savvy investors have been securing their ...
10x Genomics price target lowered to $15 from $18 at Barclays
Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares.Maximize Your ...
Impacts1d
Binance Meme Coin Battle: Wall Street Pepe 10x Potential vs Pepeto’s 100x Opportunity
Wall Street Pepe Closes Presale, Projecting 10x Returns Wall Street Pepe ($WEPE) has triumphantly wrapped up its presale ...
Crypto Briefing1d
Vitalik calls for 10X scaling to reinforce Ethereum’s L1 dominance in an L2-heavy world
Vitalik Buterin urges a 10X Ethereum scaling boost for L1 to enhance security, reduce L2 risks, and streamline application ...